On March 20-21 in London, UK, was held the prestigious 2nd ACE Clinical Trial Summit where participated  Salomea Guchmazashvili, who is pursuing doctoral studies at the School of Health Sciences, University of Georgia, as part of the Fogarty Research and Education Program funded by the United States Department of Health through the National Institutes' Fogarty International Center. Salomea's research has garnered international recognition, earning her an invitation to the Summit as one of the keynote speakers. She was allotted 30 minutes to present her findings, discuss the implications of her research, and address current issues and challenges in thyroid and reproductive health. Salomea also participated in panel discussions on both days.